Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada
Authors
Kansal AR, Sharma M, Bradley-Kennedy C, Clemens A, Monz BU, Peng S, Roskell N, Sorensen SV
Journal
Thromb Haemostasis
Publication Date
2012
Impact Factor
6.094
Abstract
Additional IDs
Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada - Publication by Dr. Andreas Clemens | Dr. Andreas Clemens